Defective antibody production in patients with rheumatoid arthritis and bronchiectasis

Clinical Rheumatology

Volumn 18, Issue 2, 1999, Pages 132-135

  Snowden, Neil ^a,c   Moran, A ^a   Booth, J ^b   Haeney, M R ^a   Swinson, D R ^b  

^a HOPE HOSPITAL   (United Kingdom)

^b WRIGHTINGTON HOSPITAL   (United Kingdom)

^c NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antibody defects; Bronchiectasis; Infection; Rheumatoid arthritis

Indexed keywords

CHLOROQUINE; GOLD; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; BRONCHIECTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNIZATION; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; ARTHRITIS, RHEUMATOID; BACTERIAL CAPSULES; BRONCHIECTASIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN ISOTYPES; LIPOPOLYSACCHARIDES; MIDDLE AGED; POLYSACCHARIDES, BACTERIAL;

EID: 0032933721     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050070     Document Type: Article

References (23)

1. Walker WC. Pulmonary infections and rheumatoid arthritis. Q J Med 1967;36:239-51.
2. MacMahon MJ, Swinson DR, Shettar S, et al. Bronchiectasis and rheumatoid arthritis: a clinical study. Ann Rheum Dis 1993;52:776-79.
3. T Solanki, E Neville. Bronchiectasis and RA: is there an association? Br J Rheumatol 1992;31:691-93.
4. Shadick NA, Fanta CH, Weinblatt ME, O'Donnell W, Coblyn JS. Bronchiectasis: a late feature of severe rheumatoid arthritis. Medicine (Baltimore) 1994;73:161-70.
5. McDonagh J, Greaves M, Wright AR, Heycock C, Owen JP, Kelly C. High-resolution CT of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 1994;33:118-22.
6. Hermaszewski RA, Webster ADB. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993;86:31-42.
7. Chapel HM (for the Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies). Consensus on diagnosis and management of primary antibody deficiencies. Br Med J 1994;308:581-85.
8. Lane PJL, MaCLennan ICM. Impaired IgG2 antibody resposes in patients with recurrent infection and normal IgG2 levels but no IgA. Clin Exp Immunol 1986;65:427-33.
9. Jefferis R, Kumararatne DS. Selective IgG sub-class deficiency: quantification and clinical relevance. Clin Exp Immunol 1990;81:357-67.
10. Lee AH, Levinson AI, Schumacher HR. Hypogammaglobulinaemia and rheumatic disease. Semin Arthritis Rheum 1993;22:252-64.
11. Hermaszewski RA, Ratnavel R, Webster ADB, Denman AM. RA in a patient with primary hypogammaglobulinaemia. Br J Rheumatol 1993;32:636-39.
12. Mageed RA, Vencovsky J, Maini RN. Rheumatoid factors and germline genes in rheumatoid arthritis: evidence of an intrinsic B-lymphocyte defect. Br J Rheumatol 1994;33:105-8.
13. Devey ME, Bleasdale K, Isenberg DA. Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with RA and SLE. Clin Exp Immunol 1987;68:562-69.
14. Hazlewood M, Nusrat R, Kumararatne DS et al.The acquisition of anti-pneumococcal capsular polysaccharide, Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK. Clin Exp Immunol 1993;93:157-64.
15. So AKL, Peskett SA, Webster ADB. Hypogammaglobulinaemia associated with gold therapy. Ann Rheum Dis 1984;43:581-82.
16. Burns HJ, Klimiuk PS, Hilton RC, Haeney M. Gold-induced hypogammaglobulinaemia. Br J Rheumatol 1987;26:53-5.
17. Snowden N, Dietch DM, Teh LS, Hilton RC, Haeney MR. Antibody deficiency associated with gold treatment: natural history and management in 22 patients. Ann Rheum Dis 1996;55:616-21.
18. Farr M, Kitas GD, Tunn EJ, Bacon PA. Immunodeficiencies associated with sulphasalazine therapy in rheumatoid arthritis. Br J Rheum 1991;30:413-17.
19. Kumararatne DS, Joyce HJ, Hazlewood M, et al. Selective deficiency of anti-polysaccharide antibodies as a risk factor for invasive disease caused by capsulated bacterial pathogens. In: Chapel HM, Levinsky RJ, Webster ADB, editors. Progress in immune deficiency III. London: Royal Society of Medicine, 1991:132-3.
20. Pincus T, Callahan LF. Taking mortality in RA seriously: predictive markers, socioeconomic status and co-morbidity. J Rheumatol 1986;13:841-8.
21. Mitchell DM, Spitz PM, Young DY, et al. Survival, prognosis and causes of death in RA. Arthritis Rheum 1986;29:706-14.
22. Musher DM, Luchi MJ, Watson DA, Hamilton R, Baughn RE. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis 1990;161:728-35.
23. French MAH, Denis KA, Dawkins R, Peter JB. Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased IgG2 and/or IgG4. Clin Exp Immunol 1995;100:47-53.